Carol Lackman-Smith - Concepedia

Author

Carol Lackman-Smith

Also Known As

C Lackman-Smith, C S Lackman-Smith, C. Lackman-Smith, CAROL LACKMAN-SMITH, Carol Lackman-Smith, Carol Lackman-Smith (359419), Carol S Lackman-Smith, Carol S. Lackman-Smith, Deena Ratner

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Southern Research Institute National Cancer Institute Frederick National Laboratory for Cancer Research National Institutes of Health National Institute of Allergy and Infectious Diseases

About

Carol Lackman-Smith is an author at Southern Research Institute specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	786
2	Natural Sciences	6	6	251
3	Biochemistry	4	4	270
4	Engineering	1	1	53
5	Allergy	1	1	54

Carol Lackman-Smith

Publications

Citations

H-Index

Page 1

	Year	Citations
Biological and Technical Variables Affecting Immunoassay Recovery of Cytokines from Human Serum and Simulated Vaginal Fluid: A Multicenter Study Raina N. Fichorova, Nicola Richardson‐Harman, Massimo Alfano, Analytical Chemistry	2008	179
Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms James B. McMahon, Michael J. Currens, Robert J. Gulakowski, Antimicrobial Agents and Chemotherapy Distinct MechanismsBiochemistryHiv Life CycleMedicineHuman Retrovirus	1995	125
T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1 J O Ojwang, Robert W. Buckheit, Yves Pommier, Antimicrobial Agents and Chemotherapy Hiv-1 IntegrasePotent InhibitorImmunologyMolecular BiologyT30177 Inhibited Replication	1995	104
Development of a Comprehensive Human Immunodeficiency Virus Type 1 Screening Algorithm for Discovery and Preclinical Testing of Topical Microbicides Carol Lackman-Smith, Clay Osterling, Katherine Luckenbaugh, Antimicrobial Agents and Chemotherapy ImmunologyDermatologyScreening AlgorithmAntiviral DrugHuman Retrovirus	2008	102
Potent and Specific Inhibition of HIV Envelope-Mediated Cell Fusion and Virus Binding by G Quartet-Forming Oligonucleotide (ISIS 5320) Robert W. Buckheit, Joseph L. Roberson, Carol Lackman-Smith, AIDS Research and Human Retroviruses Viral ReplicationImmunologyMolecular BiologyVirus BindingAntiviral Drug	1994	77
Phosphorothioate Oligonucleotides Inhibit Human Immunodeficiency Virus Type 1 Fusion by Blocking gp41 Core Formation Andrew Vaillant, Jean–Marc Juteau, Hong Lü, Antimicrobial Agents and Chemotherapy Molecular BiologyAntiviral DrugChemical BiologyHuman RetrovirusAntisense Therapy	2006	70
Stability-Activity Relationships of a Family of G-tetrad Forming Oligonucleotides as Potent HIV Inhibitors Naijie Jing, Erik De Clercq, Robert F. Rando, Journal of Biological Chemistry Potent Hiv InhibitorsGlycobiologyMolecular BiologyCell CultureAntiviral Drug	2000	54
In Vitro Preclinical Testing of Nonoxynol-9 as Potential Anti-Human Immunodeficiency Virus Microbicide: a Retrospective Analysis of Results from Five Laboratories Brigitte Beer, Gustavo F. Doncel, Fred C. Krebs, Antimicrobial Agents and Chemotherapy Vitro Preclinical TestingImmunologyRetrospective AnalysisAntiviral DrugImmunotherapy	2006	54
Multisite Comparison of Anti-Human Immunodeficiency Virus Microbicide Activity in Explant Assays Using a Novel Endpoint Analysis Nicola Richardson‐Harman, Carol Lackman-Smith, Patricia Fletcher, Journal of Clinical Microbiology EngineeringImmunologyBiomedical EngineeringAntiviral DrugHuman Retrovirus	2009	53
Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals Elizabeth R. Wonderlich, Krupa Subramanian, Bryan D. Cox, PLoS Pathogens Viral ImmunityImmunologyIntensive ArtHiv-1 Latency ReversalImmunotherapy	2019	44

Page 1